Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design.
Journal: Contemporary clinical trials communications
Published: November 03, 2020
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
Journal: The lancet. Diabetes & endocrinology
Published: August 20, 2020
Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome.
Journal: Diabetes, obesity & metabolism
Published: May 20, 2020
Reduced radiation exposure in the cardiac catheterization laboratory with a novel vertical radiation shield.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: July 29, 2019
Showing 1-4 of 4
Last Updated: 09/26/2026